the real question is why are the brands not being properly marketed? is CR still trying to be "different?" watch the sweepstakes and labeling changes impact earnings.
what a nice time to establish your brand. unfortunately, the marketing campaign looks like it was conceived by pet cat. sweepstakes are a joke. a lazy device that does not have any lasting impact or maybe any impact at all. it is the strategy of CR as a hobbyist. 25 years and still losing money? think about it. #$%$? was it a 25 year long fluke? look at what GT did in far less than 25 years. how is it that REED has faired so poorly by comparison as a beverage company?
no, he is saying you should have sold already. when the smart money realized chris reed was spouting more bs excuses about why the sales went up but the losses went that way and the the yen did that, etc...
how dare you sir? reeds is the coke of the natural beverage market. how indeed could GT impact Reeds? impossible! wait, i think reeds is the coke of the natural carbonated root beer or ginger brew four pack market. so actually i guess gt could kick its #$%$. unless.... unless they take out a print in ad in vegetarian news times week. that my friend is how you market kombucha. (as opposed to sending out tasting demonstration representatives which is very labor intensive and not cool man). me, i get all my beer preferences from print ads. i think most people do.
hey dumbasarock. what are the total options outstanding at that price? you think that tiny, tiny quantity amount controls 100 million shares? or the other way around? please please stop posting.
sam, that is essentially a sell notation by RBC in support of the short position. remember its a billion dollar plus short. they are not to be taken lightly. the buying pressure is not supported by volume yet. so the shorts can break this rally easily. i expect they will without support of news from mygn. there is NO short squeeze here. someday. but not now. and carolyn is an abject moron.
the buying was quarter end re-balancing. it is overbought technically (just and indication). the shorts are not on the run at this point. dont get too happy just yet.
sorry, it is more evidence of a lack of understanding of the market and the idea of a hobbyist. they have been pushing the idea of mainstream distribution for K. of course GT utterly dominates the health category so that makes sense to seek new markets. but there is no marketing support for mainstream. instead they are marketing in vegan print? the product is not configured to succeed in vegan/health. GT is. hence the slowing sales. there is no marketing vision. hire someone from hansens or red bull for pete's sake. stop trying to re-invent the wheel. breakfast mountain dew, first year sales forecasts are 100 million. breakfast mountain dew. hire the guy who markets breakfast mountain dew.
i was afraid of this. the IOT build-out appears to be headed by companies who essentially leap-frogged elon. so they have a legacy system that may be appealing to utilities somewhat but i think a google or samsung has no interest in what they have to say at elon. they easily could have been Nest but they forgot to innovate. it would appear that a bankruptcy is almost being priced in at this point. another poor quarter and i think the ship is abandoned. so much dynamic change in IOT and nothing out of elon it seems.
i doubt this is a coincidence. if new management is going to be more aggressive, then you need a different guy to run that expansion. however, i still see no business plan. what am i missing?
went into fairway and there on the shelf was reeds K positioned above all the GT. the GT was moved to the two lowest shelves with reed having 10 or so facings on most of one shelf. i think the labels were redesigned, but still terrible labels. not on sale either. $3.29 each. so more expensive than the GT for less product.
what a silly post. how is it undervalued? they have no sales. but the company is valued at 30 million dollars. not 3 million. 30 million. like they make 1.5 million in profit. you know when they are going to make 1.5 million in net profit? maybe never. maybe if we are lucky in a few years. maybe. you do not even know a margin, yet you make statements about valuation. i own shares in REED. they have 40,000,000 in sales and are valued at 60 million. pure has no sales and is valued at 30 million. but it is undervalued? i think it would be fairly valued now in the 20 cent range. it is actually wildly, wildly overvalued until a business model emerges. what is even the margin on sales? a 5% royalty? more? so to have 5 million in royalties they need 100 million in sales?
that does not bode well short term, but i dont think the impact will be too great in the absence of news. technically, you would sell it here and buy it back a bit lower.
and continuing millions in losses. the fact that they hired young mr. cfo with no apparent relevant experience is a really bad, bad sign.
you must not have gone into the fiat dealership. that is really where they are pushing soda sales. jen clueless realized that they share the same market (average purchasers of fiat are 52). so carrie is leaving and the guy who was cfo before the monster collapse of jones (back at age 26 ) is back. fresh from his software gig. wow. impressive. having that great industry experience will certainly help jones. collapsed soda company and software. savvy move. the lack of experience in a successful beverage business will be a refreshing change. no preconceptions.
please stop posting. i can not conceive that a person with money to invest could be as incredibly dumb as your posts are. did you hit your head?
lol. they do not believe the analysts. the analysts publish what they are paid to publish. short money is seldom dumb money. i have no explanation as to what is happening with this size short position after the guidance was raised. if you notice, very few analysts have defended mygn. even zacks backed off.
personally i believe that market data is completely fictional as is the level 2 data. however, i am quite surprised that the short position was not significantly trimmed. it does not seem an appealling bet to me. especially as the news stream from mygn is not likely to be consistently negative. too many biotech moves up that were violent lately. if you look at the analysts reports, they are calling for a decline in eps next year.
even more odd is the fact that the shorts have become passive. it would be easy to squash mygn for $2-3 dollars here (or a quick hundred million in paper profits) since the buying has been on rather low volume. for some reason they have let it float up. it is no longer oversold like it was, but the behavior is odd and weirdly risky. i also do not see any/much hedging with open interests on calls. i would not be surprised to see mygn have a big down day.
the marketing strategy of the entire company has been based on this dependence on social media. and even though the company is clearly failing and approaching closure, they keep at it. now their bign effort for the summer is targeting 52 year olds. because they dont know what they are doing. almost two years of effort and trading at the 52 week low? it is called failure. or do they need another several years?